Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study). / Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII).

OBJECTIVE: The recommendations of the Spanish Ministry of Health on vaccination in risk groups include mesalazine among the treatments with a possible negative effect on its effectiveness. However, this is not the recommendation of most experts. Our objective was to evaluate the effect of mesalazine on the humoral response to the SARS-CoV-2 vaccine in patients with inflammatory bowel disease (IBD). METHODS: VACOVEII is a Spanish, prospective, multicenter study promoted by GETECCU, which evaluates the effectiveness of the SARS-CoV-2 vaccine in patients with IBD. This study includes IBD patients who have recieved the full vaccination schedule and without previous COVID-19 infection. Seroconversion was set at 260BAU/mL (centralized determination) and was assessed 6 months after full vaccination. In this subanalysis of the study, we compare the effectiveness of the vaccine between patients treated with mesalazine and patients without treatment. RESULTS: A total of 124 patients without immunosuppressive therapy were included, of which 32 did not receive any treatment and 92 received only mesalazine. Six months after full vaccination, no significant differences are observed in the mean concentrations of IgG anti-S between both groups. In the multivariate analysis, antibody titers were independently associated with the use of mRNA vaccines and with SARS-CoV-2 infection. CONCLUSION: Mesalazine does not have a negative effect on the response to SARS-CoV-2 vaccines in IBD patients.

Comparación entre las técnicas de cribado de patología cervical y las conizaciones de tres hospitales en España / Comparison between cervical pathology screening techniques and the conizations of three hospitals in Spain

OBJETIVO Analizar las características poblacionales y los métodos diagnósticos de patología cervical para la prevención del cáncer de cérvix de tres hospitales españoles para mejorar y unificar los programas de cribado y prevención. MATERIAL Y MÉTODOS Estudio retrospectivo de las características demográficas y clínicas de 408 mujeres con patología cervical uterina diagnosticadas en 3 hospitales españoles. Se comparan los factores de riesgo, el proceso diagnóstico y la indicación de tratamiento de dos grupos: las que requirieron conización cervical (n=222) y las que no precisaron tratamiento quirúrgico (n=186). También se analizan las recomendaciones vacunales y su grado de cumplimiento. RESULTADOS Las mujeres conizadas usaron más anticoncepción hormonal y tienen un mayor hábito tabáquico mientras que el número de compañeros sexuales es mayor en pacientes no conizadas. Más del 50% de pacientes con biopsia cervical positiva presentaron un resultado igual o más grave en la anatomía patológica de la pieza quirúrgica. Existen diferencias significativas en sensibilidad y valor predictivo positivo de la citología y de la determinación de HPV entre hospitales. La recomendación de vacunación en ambos grupos fue similar, el porcentaje de mujeres que no la cumplieron fue elevado y significativamente mayor entre pacientes conizadas. CONCLUSIÓN En nuestro medio las mujeres conizadas tienen características clínicas y epidemiológicas diferentes a las no conizadas, existen diferencias entre las técnicas diagnósticas de distintos hospitales y sin embargo la concordancia entre biopsia y resultado del cono es elevada. Sigue siendo necesaria una correcta educación sanitaria en relación con la vacunación en mujeres con patología cervical.

BACKGROUND To analyse the characteristics of the population and diagnostic methods related to the cervical cancer prevention program in three different-level hospitals of a Spanish region in order to improve and unify the screening program. METHODS We retrospectively studied demographic and clinical characteristics of 408 women with cervical lesions diagnosed in three hospitals in Aragon (Spain). Correlation between risk factors, diagnosis process and conisation indication was analysed divided in two groups: conisation required (n=222) or non-conisation (n=186). We also assessed the number of vaccine recommendations made to the patients and the degree of compliance. RESULTS Conisaited women more frequently used a combined hormonal contraceptive method and are more smokers, while the sexual partners are more in women without conisation. More than 50% of women con positive biopsy was confirmed after surgical treatment. There are significant differences between sensibility and positive predictive value of pap-smear and HPV determination in different hospitals. The recombinant vaccine was recommended to both groups at a similar rate. The percentage of women who were recommended to receive the vaccine but chose not to do it, was high in both groups but significantly higher in the Conisation group. CONCLUSION In our environment conisaited women have different clinical and epidemiological profiles, there are differences between diagnosis techniques in different hospitals, however, the concordance between biopsy and definitive result is high. A good sanitary education is necessary in relation with the vaccination of women with cervical pathology.

Trombofilia, complicaciones vasculares gestacionales, criterios de elegibilidad y consejo anticonceptivo / Thrombophilia, gestational vascular complications, eligibility criteria, and contraceptive counseling

Objetivo: detectar mujeres con alguna complicación vascular gestacional posiblemente relacionada con trombofilia y realizar consejo anticonceptivo. Material y métodos: estudio prospectivo descriptivo que incluye todas las complicaciones vasculares gestacionales del 2012 en el Hospital Clínico Universitario Lozano Blesa de Zaragoza. Se realizó estudio de trombofilia genética, plasmática y de factores de riesgo trombótico. Se ofrecen recomendaciones de hábitos de vida y anticoncepción basadas en los criterios de elegibilidad de la Organización Mundial de la Salud. Resultados: de 351 mujeres aceptan participar 136. 46,7% presentaban al menos un factor de riesgo trombótico diferente de trombofilia. 38,2% presentaban trombofilia, siendo el 90,4% defectos únicos. Para el consejo anticonceptivo se han utilizado los criterios de elegibilidad de la Organización Mundial de la Salud así como las preferencias de cada mujer, individualizándose su riesgo, según también otros factores de riesgo trombótico. Conclusiones: la trombofilia en la obstetricia es un tema en auge, el estudio de esta asociación podría ser útil para ofrecer recomendaciones para futuras gestaciones, anticoncepción y profilaxis de enfermedad tromboembólica venosa (AU)

Objective: Pregnancy vascular complication probably related with maternal thrombophilia detection and contraceptive counsel. Material and Methods: Prospective and descriptive study including every pregnancy vascular complication in 2012 in the University Clinical Hospital Lozano Blesa of Zaragoza. A thrombophilia plasmatic and genetic, and thrombosis risk factors was accomplished. Some life habits recommendations and contraception counsel based in elegibility World Health Organization criteria were given to women. Results: From 351 women 136 agree to participate. 46.7% of patients present at least one trombotic different risk factor of thrombophilia. 38.2% present thrombophilia being the 90.4% only defaults. Contraceptive counsel were given based on World Health Organization elegibility criteria, as women preferences and individual risk according to other thrombotic risk factors. Conclusions: Thrombophilia in Obstetrics is a booming topic, this association study can be used to future pregnancy recommendations, contraception counsel and thromboprophylaxis (AU)

Dolor abdominal agudo como presentación de un linfoma ovárico / Acute abdominal pain as presentation of an ovarian lymphoma

Antecedentes: El linfoma no Hodgkin de ovario es una patología infrecuente, más aun el ovárico primario. Caso Clínico: Presentamos el caso de una paciente con antecedente de diverticulitis aguda y varios episodios posteriores de dolor abdominal agudo, fiebre y aumento de reactantes de fase aguda con pruebas de imagen no concluyentes. A pesar de la buena respuesta inicial al tratamiento antibiótico, durante uno de los episodios la paciente precisa intervención quirúrgica urgente. Durante la intervención se halla una enfermedad tumoral avanzada con diagnóstico histológico de linfoma difuso de células grandes B. Conclusión: En el diagnóstico diferencial ante una sintomatología similar a la de nuestra paciente, se debería tener presente la posibilidad de un linfoma ovárico, a pesar de su baja incidencia.

Background: Non-Hodgkin's lymphoma of the ovary is an infrequent pathology, even more primary one. Clinical case: We report a patient with a history of acute diverticulitis and several episodes of acute abdominal pain, fever and increased acute phase reactants with inconclusive imaging tests. Patient required urgent surgery during one episode despite a good initial response to antibiotic therapy. A locally advanced tumour disease was found in surgical intervention which was diagnosed as a diffuse large B-cell lymphoma. Conclusion: In the differential diagnosis in a manner similar to that of our patient symptoms, we should keep in mind the possibility of an ovarian lymphoma despite their low incidence.